Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 5,650 | 13,114 | 6,217 | 3,647 | 2,719 |
| Gross Profit | 5,650 | 13,114 | 6,217 | 3,647 | 2,719 |
| Operating Expenses | 24,480 | 20,886 | 24,434 | 23,344 | 20,018 |
| Operating Income | -18,830 | -7,772 | -18,217 | -19,697 | -17,299 |
| Interest Expense | 127 | 19 | 209 | 243 | 0 |
| Other Income | 71 | 28 | 134 | 36 | 655 |
| Pre-tax Income | -18,886 | -7,763 | -18,292 | -19,904 | -16,644 |
| Income Tax | N/A | N/A | 1,129 | 176 | 857 |
| Net Income Continuous | -18,886 | -7,763 | -19,421 | -20,080 | -17,501 |
| Net Income | $-18,886 | $-7,763 | $-19,421 | $-20,080 | $-17,501 |
| EPS Basic Total Ops | -0.40 | -0.21 | -0.59 | -0.72 | -0.61 |
| EPS Basic Continuous Ops | -0.40 | -0.21 | -0.59 | -0.72 | -0.61 |
| EPS Diluted Total Ops | -0.40 | -0.21 | -0.59 | -0.72 | -0.61 |
| EPS Diluted Continuous Ops | -0.40 | -0.21 | -0.59 | -0.72 | -0.61 |
| EBITDA(a) | $-17,869 | $-7,058 | $-17,674 | $-19,155 | $-16,820 |